Puma Biotechnology Says Jury Verdict Was Entered In Favor Of Wyeth, And Against AstraZeneca; Jury Found '314 & '162 Patents To Be Infringed By AstraZeneca And Not Invalid, Awarded Plaintiffs $107.5M In Damages
Puma Biotechnology Says Jury Verdict Was Entered In Favor Of Wyeth, And Against AstraZeneca; Jury Found '314 & '162 Patents To Be Infringed By AstraZeneca And Not Invalid, Awarded Plaintiffs $107.5M In Damages
Puma Biotechnology稱陪審團的裁決有利於惠氏，對阿斯利康不利；陪審團裁定'314和'162項專利受到阿斯利康侵權且無效，判給原告1.075億美元的賠償金
Puma Biotechnology Says Jury Verdict Was Entered In Favor Of Wyeth, And Against AstraZeneca; Jury Found '314 & '162 Patents To Be Infringed By AstraZeneca And Not Invalid, Awarded Plaintiffs $107.5M In Damages
Puma Biotechnology稱陪審團的裁決有利於惠氏，對阿斯利康不利；陪審團裁定'314和'162項專利受到阿斯利康侵權且無效，判給原告1.075億美元的賠償金
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。